<DOC>
	<DOCNO>NCT02811055</DOCNO>
	<brief_summary>Aldosterone regulation mediate hormonal control , nervous control . Autonomic nervous system action could mediate neuropeptides adrenal gland . Therefore , pathological condition especially diabetes , low-renin hypertension normal high plasma aldosterone could cause sympathetic nervous system hypertonia . Data literature previous vitro research conduct investigator ' laboratory ( INSERM U982 , University Rouen ) suggest adrenal corticosteroid secretion might control sympathetic nervous system . This neurocrine regulation corticosteroid secretion involve locally release neuropeptides . Among , substance P able stimulate aldosterone cortisol production via NK1 receptor . A previous clinical trial conduct University Hospital Rouen , APHOS ( NCT00977223 ) study effect NK1 receptor antagonist , aprepitant , adrenocortical secretion healthy volunteer . The aim present study investigate effect NK1 receptor antagonist , aprepitant , adrenocortical secretion volunteer diabetes associate low-renin hypertension . Aprepitant drug already available treatment nausea induce chemotherapy . In present phase II trial , plasma aldosterone cortisol level measure treatment aprepitant versus placebo , basal condition activation adrenocortical function upright posture . All volunteer give two substance ( aprepitant placebo ) random order two 14 day-periods separate 21 day-wash-out . This study allow determine role substance P control corticosteroid production human diabetes , associate low-renin hypertension .</brief_summary>
	<brief_title>Pilot Study Aprepitant Effect Aldosterone Secretion Diabetic Patient ( Diabetes Mellitus ) With Hypertension Associated With Low Renin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<criteria>Male menopausal female subject ; Age range 1830 year old ; Submitted social security regimen ; Agreeing study &amp; Informed consent form sign ; Body mass index ( [ weight ( kg ) /height ( ) ] Â² ) &lt; 27 ; No treatment receive 6 week inclusion ; No anomaly : complete clinical examination , pulse blood pressure measurement , ECG ; No biological abnormality follow biological testing : Hematology : white &amp; red blood cell &amp; platelet count , haemoglobin , hematocrit , Blood biochemistry : sodium , potassium , chloride , bicarbonate , creatinine , urea , Urinary biochemistry ( 24 h collection ) : cortisol , aldosterone , Serologies : HIV , HBV , HCV , No participation clinical trial 3 month ago inclusion , Subscription national social security , Signed inform consent . Female subject potentially pregnant , Subject young 18 yearold old 70 yearold , Subject without diabetes condition diabetes normal blood pressure ( 130/80 mmHg ) , Subject glycated hemoglobin HbA1c &lt; 6.5 % &gt; 11 % , Subject leuconeutropenia ( neutrophils 1700/mm3 ) , Subject severe medical surgical history , Patients treat drug metabolize CYP3A4 CYP2C9 : corticosteroid , vitamin K , hormonal contraceptive , tolbutamide , benzodiazepine , derive ergot , antiepileptic , hypericum , macrolides , azole antifungal . Patients treat drug interfere reninangiotensin aldosterone system : betablockers , diuretic , anti aldosterone drug , direct renin inhibitor , insulin , type 2 diabetes patient vegetative autonomic neuropathy , Patients adrenal mass diagnose imaging , hepatic renal impairment ( define respectively secondary clinical biological manifestation alter hepatocyte function estimate glomerular filtration rate le 60 mL / min / 1.73 m2 ) ; nephrotic syndrome ( define hypoalbuminemia less 30 g / L associate proteinuria 3 gram / 24 hour ) ; edematous syndrome ( define presence edema lower limb ) , Orthostatic hypotension ( defined decrease systolic blood pressure 20 mmHg least diastolic blood pressure 10 mmHg ) , arrhythmias cardiac conduction , heart failure ( NYHA class II minimum ) , epilepsy , serious psychiatric condition , Severe allergic history , hypersensitivity aprepitant , People hereditary problem fructose intolerance , glucose malabsorption , galactose , sucraseisomaltase , People lactose intolerance , subject unwilling follow regularly . Persons deprive liberty judicial administrative decision , hospitalize without consent admit health social establishment purpose research , adult subject measure legal protection unable consent may include .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>